Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

The company’s recent market study titled 'Benign Prostatic Hyperplasia Prostate Treatment Market: Global Industry Analysis 2013-2017 & Opportunity Assessment 2018-2028' comprises a comprehensive assessment of the key market dynamics. Through detailed research on the growth parameters of the benign prostatic hyperplasia prostate treatment market, growth forecasts of the market have been obtained with maximum accuracy.

The report features exclusive and significant factors that have a huge impact on the development of the benign prostatic hyperplasia prostate treatment market during the forecast period. These factors can aid market players in developing marketing and manufacturing strategies, and visualize maximum growth in the benign prostatic hyperplasia prostate treatment market during the forecast years. The report offers thorough information about the growth prospects of the benign prostatic hyperplasia prostate treatment market in a comprehensive way for a better understanding of readers.

Chapter 1 – Executive Summary

The report begins with the executive summary of the benign prostatic hyperplasia prostate treatment market, which includes a detailed summary of the key findings, statistics, and technology roadmap of the market. It also includes the market value (US$ million) estimations of leading segments in the benign prostatic hyperplasia prostate treatment market.

Chapter 2 – Market Introduction and Overview

The report summaries the detailed taxonomy and definitions, which are key to understanding the basic information regarding the benign prostatic hyperplasia prostate treatment market dynamics, key players, pricing analysis, and regulation policies of this market.

Chapter 3 – Global Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Treatment Type

Based on treatment type, the benign prostatic hyperplasia prostate treatment market has been segmented into drugs and devices. The drugs segment of the benign prostatic hyperplasia prostate treatment market is segmented into alpha-blockers, alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs. The devices segment in the benign prostatic hyperplasia prostate treatment market is segmented into prostatic stents, suture base implant systems, and transurethral RF thermal therapy. Readers can find detailed information regarding the key market trends, developments, and market attractive analysis of the benign prostatic hyperplasia prostate treatment market based on treatment type.

Chapter 4 – Global Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Distribution Channel

In terms of the distribution channel, the benign prostatic hyperplasia prostate treatment market is segmented into institutional sales, retail sales, and online pharmacies. Further, the institutional sales segment is sub-segmented into hospitals, ambulatory surgical centers, and specialty clinics. The retail sales segment is sub-segmented into retail pharmacies and drug stores.

Chapter 5 – Global Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028 by Region

This chapter provides detailed information regarding the current growth scenario of the benign prostatic hyperplasia prostate treatment market across various geographic regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and the Middle East & Africa (MEA).

Chapter 6 – North America Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes a detailed analysis of the North America benign prostatic hyperplasia prostate treatment market growth, along with a country-wise assessment, including the U.S. and Canada. Readers can find detailed information regarding regional trends, macroeconomic factors, and market growth based on treatment type, distribution channel, and country, in the North America benign prostatic hyperplasia prostate treatment market.

Chapter 7 – Latin America Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter consists of the growth forecasts for the Latin America benign prostatic hyperplasia prostate treatment market in leading countries such as Brazil, Mexico, and the Rest of Latin America. Readers can also find detailed information regarding factors such as pricing analysis, regional trends, and growth factors that are influencing the growth of the Latin America benign prostatic hyperplasia prostate treatment market.

Chapter 8 – Europe Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

In this chapter, readers can find detailed information regarding key growth forecasts of the benign prostatic hyperplasia prostate treatment market based on applications in various European countries such as the U.K., Germany, France, Italy, Spain, Russia, and the Rest of Europe.

Chapter 9 – South Asia Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes the growth prospects of the benign prostatic hyperplasia prostate treatment market in leading South Asian countries such as India, Thailand, Indonesia, Malaysia, and the Rest of South Asia.

Chapter 10 – East Asia Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

This chapter includes the growth prospects of the benign prostatic hyperplasia prostate treatment market in leading East Asian countries such as China, Japan, and South Korea.

Chapter 11 – Oceania Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

In this chapter, readers can find detailed information regarding several parameters influencing the Oceania benign prostatic hyperplasia prostate treatment market during the forecast period 2018-2028. Australia and New Zealand are the leading countries in Oceania that are the prime subjects of assessment to obtain the growth prospects of the Oceania benign prostatic hyperplasia prostate treatment market.

Chapter 12 – MEA Benign Prostatic Hyperplasia Prostate Treatment Market Analysis 2013-2017 & Opportunity Assessment 2018-2028

Readers can find thorough information regarding the growth factors that are impacting the MEA benign prostatic hyperplasia prostate treatment market, and gain insights on how the benign prostatic hyperplasia prostate treatment market is likely to impact the main countries/region in MEA, such as GCC Countries, Turkey, North Africa, South Africa, and the Rest of MEA, over the forecast period 2018-2028.

Chapter 13 – Competition Landscape, Company Share, and Company Profiles

This chapter provides readers a wide-ranging list of all the prominent key players in the benign prostatic hyperplasia prostate treatment market, along with detailed information regarding each company, including company overview, offered products, revenue shares, key strategy, and recent company developments.

Chapter 14 – Assumptions and Acronyms

This chapter in the benign prostatic hyperplasia prostate treatment market report includes a list of assumptions and acronyms that provide a base to the statistics and information included in the report.

Chapter 15 – Research Methodology

This chapter in the benign prostatic hyperplasia prostate treatment market report provides readers with a detailed research methodology employed to obtain various conclusions and important qualitative and quantitative information regarding the benign prostatic hyperplasia prostate treatment market.